0001437749-16-034614.txt : 20160629 0001437749-16-034614.hdr.sgml : 20160629 20160629160125 ACCESSION NUMBER: 0001437749-16-034614 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160628 FILED AS OF DATE: 20160629 DATE AS OF CHANGE: 20160629 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oxford Immunotec Global PLC CENTRAL INDEX KEY: 0001586049 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 94C INNOVATION DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ BUSINESS PHONE: 44 01235 442780 MAIL ADDRESS: STREET 1: 94C INNOVATION DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SANDBERG RICHARD A CENTRAL INDEX KEY: 0001245055 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36200 FILM NUMBER: 161738838 MAIL ADDRESS: STREET 1: 330 NEVEDA STREET CITY: NEWTON STATE: MA ZIP: 02460-1458 4 1 rdgdoc.xml FORM 4 X0306 4 2016-06-28 0001586049 Oxford Immunotec Global PLC OXFD 0001245055 SANDBERG RICHARD A C/O OXFORD IMMUNOTEC GLOBAL PLC 94C INNOVATION DRIVE ABINGDON, OXFORDSHIRE X0 OX14 4RZ UNITED KINGDOM 1 SHARE OPTION (RIGHT TO BUY) 8.65 2016-06-28 4 A 0 7457 0 A 2026-06-28 ORDINARY SHARES 7457 7457 D The option will vest and become exercisable as to 100% of the underlying shares on the date of the first annual meeting of the issuer's shareholders held after the date of grant. /s/ Anthony P. Ferman, as Attorney-in-Fact for Richard A. Sandberg 2016-06-29